More about

Hereditary Angioedema

News
October 06, 2022
1 min read
Save

FDA grants priority review to lanadelumab-flyo for pediatric hereditary angioedema attacks

FDA grants priority review to lanadelumab-flyo for pediatric hereditary angioedema attacks

The FDA has granted priority review to a supplemental biologics license application for the potential expanded use of lanadelumab-flyo to prevent hereditary angioedema attacks in patients aged 2 to younger than 12 years.

News
September 02, 2022
2 min read
Save

Prader-Willi syndrome complicates hereditary angioedema diagnosis

Prader-Willi syndrome complicates hereditary angioedema diagnosis

Prader-Willi syndrome can delay the diagnosis of hereditary angioedema, which already can be difficult to identify, according to a case report published in Annals of Allergy, Asthma & Immunology.

News
July 01, 2022
3 min read
Save

Lanadelumab prevents hereditary angioedema attacks in children

Lanadelumab prevents hereditary angioedema attacks in children

Lanadelumab prevented hereditary angioedema attacks among patients aged 2 to younger than 12 years with no serious adverse events, according to a study presented at European Academy of Allergy and Clinical Immunology Hybrid Congress.

News
June 01, 2022
3 min read
Save

Prophylactic therapy with subcutaneous C1 inhibitor reduces hereditary angioedema attacks

Prophylactic therapy with subcutaneous C1 inhibitor reduces hereditary angioedema attacks

Long-term subcutaneous treatment with a C1 inhibitor decreased the frequency and severity of hereditary angioedema attacks as well as the use of on-demand medications, according to a study published in Allergy and Asthma Proceedings.

News
May 15, 2024
2 min watch
Save

VIDEO: More oral medication options needed for hereditary angioedema

VIDEO: More oral medication options needed for hereditary angioedema

In this video, Douglas Jones, MD, Director of Rocky Mountain Allergy at Tanner Clinic, discusses the major unmet needs in the treatment of hereditary angioedema.

News
May 15, 2024
1 min watch
Save

VIDEO: Heavy activity in hereditary angioedema drug pipeline

VIDEO: Heavy activity in hereditary angioedema drug pipeline

In this video, Douglas Jones, MD, Directory of Rocky Mountain Allergy at Tanner Clinic, discusses the current state of the pipeline for hereditary angioedema treatment.

News
May 15, 2024
2 min watch
Save

VIDEO: ‘Meeting the patient where they are’ key to hereditary angioedema treatment planning

VIDEO: ‘Meeting the patient where they are’ key to hereditary angioedema treatment planning

In this video, Douglas Jones, MD, Director of Rocky Mountain Allergy at Tanner Clinic, discusses how he approaches putting together treatment plans for hereditary angioedema patients, and how understanding patients' individual situation is a major key.

News
May 15, 2024
1 min watch
Save

VIDEO: Importance of acknowledging, validating patients’ challenges in hereditary angioedema

VIDEO: Importance of acknowledging, validating patients’ challenges in hereditary angioedema

In this video, Douglas Jones, MD, Director of Rocky Mountain Allergy at Tanner Clinic, discusses how he approaches managing quality of life for hereditary angioedema patients.

News
September 26, 2024
2 min watch
Save

VIDEO: Personalized approach key to balancing preventative vs. on-demand HAE treatments

VIDEO: Personalized approach key to balancing preventative vs. on-demand HAE treatments

In these videos, Marc Riedl, MD, an allergist/immunologist at UC San Diego Health, discusses promising new treatments for hereditary angioedema.

News
September 26, 2024
2 min watch
Save

VIDEO: Disparities exist in access to hereditary angioedema specialists, medications

VIDEO: Disparities exist in access to hereditary angioedema specialists, medications

In these videos, Marc Riedl, MD, an allergist/immunologist at UC San Diego Health, discusses care disparities that exist for patients with HAE.

View more